Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
XRP crypto eyes rally as price breaks $2.34 level: Is a $6 rally next?

XRP crypto eyes rally as price breaks $2.34 level: Is a $6 rally next?

Crypto.NewsCrypto.News2025/07/08 16:00
By:By David MarsanicEdited by Jayson Derrick

If XRP manages to stay above $2.34, a rally toward $6 is possible, says Arthur Azizov of B2 Ventures.

XRP has been trading within its current range since December. However, the token may be positioning for a major rally. On Wednesday, July 9, it reached a monthly high of $2.40 and managed to sustain its momentum even after a brief correction, trading at $2.37.

Arthur Azizov, founder and investor at B2 Ventures, believes that if XRP holds a key support level, it could push to new highs, potentially even record territory. The first major resistance, he noted, lies at $2.65.

“XRP is currently trading near a key level. If the price manages to hold above $2.34 and stays above this mark, it is likely to move towards a new high around $2.65,” Arthur Azizov, B2 Ventures.

Currently, XRP traders are accumulating tokens, but the price has remained relatively stable. Azizov attributes this to XRP’s tendency to move independently of broader market dynamics. Despite that, the overall outlook for the token is bullish.

“Since XRP has been in accumulation for quite a long time, the outlook remains positive. Most likely, the breakout will be to the upside, with targets in the $4–6 range,” Arthur Azizov, B2 Ventures.

XRP crypto fundamentals remain strong: Azizov

A move above $3.84 would mark a new all-time high for XRP, last reached in January 2018. Several fundamental factors may now support such a move.

For one, XRP has expanded its partnerships with major institutions. Additionally, a growing number of XRP-focused ETF applications have been filed in the U.S., signaling investor anticipation of increased demand.
Its largest ETF, the Teucrium 2x Long Daily XRP, saw its biggest weekly inflows since launch, registering at $158 million in July.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "Outlier" Investment Art in the New Era of Berky

他山之石观投资2026/09/14 09:22
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

智通财经2026/09/14 09:12
Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

智通财经2026/09/14 08:57
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales

Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

智通财经2026/09/14 08:41
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales